Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Identify smart fund options for retirement diversification, focusing on balance, risk management, and practical allocation ideas for real-world use.
24,189 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
The latest nationwide data reveal a 7.6% drop in new foreclosure filings, but a closer look shows pockets of rising d...
When a high-profile project runs $114 million over budget, it’s not just news for state treasuries. It’s a real-life ...
A viral parody drawing 110 million views isn’t just a pop culture moment—it also tests money decisions. This guide sh...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
A fast-moving convergence of quantum computing and robotics is reshaping portfolios. Three ETFs—QTUM, BOTZ, and ROBO—...
A narrow, theme-driven ETF focused on generative AI shows mixed results as broader AI funds rally. The concentrated a...
Stocks push to new highs as AI-driven earnings lift equities, while bitcoin falling behind record-breaking rallys rem...
Investors are watching the Fed for its next move, a key factor in whether GLD can extend its recent 36% rally. Real y...
Tech-led gains push major indices higher on June 9, 2026, with the S&P 500 and Nasdaq leading the rally as investors ...
In the month since THYP debuted on Nasdaq, hype etfs quietly pulled $161 million in net inflows across the three US-t...
The Federal Reserve holds rates steady, but new chair Kevin Warsh’s hawkish cues spurred a late-day market pullback. ...